chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: "felt like punch in arm"; bad mosquito bite; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA ("felt like punch in arm") and VACCINATION SITE PAIN (bad mosquito bite) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C24C) for COVID-19 vaccination.     The patient's past medical history included Biopsy tendon (BICEP REPAIR SURGERY) and Vasectomy. Concomitant products included LISINOPRIL, DULOXETINE and PRAVASTATIN for an unknown indication.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced MYALGIA ("felt like punch in arm") and VACCINATION SITE PAIN (bad mosquito bite). The patient was treated with TRAMADOL at a dose of 2 PILLS and TRAMADOL at an unspecified dose and frequency. At the time of the report, MYALGIA ("felt like punch in arm") and VACCINATION SITE PAIN (bad mosquito bite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication of Multivitamins(NOS)  taken as reported by the patient.    This case was linked to MOD-2021-214603 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient taken second dose 50 days after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient taken second dose 50 days after first dose) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 042B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient taken second dose 50 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient taken second dose 50 days after first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were used. No Treatment medication were used
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Pyrexia, Vaccination complication, Vertigo
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of VERTIGO (Vertigo), VACCINATION COMPLICATION (Reacted pretty significantly), FEELING ABNORMAL (Felt a little funky), FATIGUE (Tired) and PYREXIA (Had a feeling like she was going to have a fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo), VACCINATION COMPLICATION (Reacted pretty significantly), FEELING ABNORMAL (Felt a little funky), FATIGUE (Tired) and PYREXIA (Had a feeling like she was going to have a fever). At the time of the report, VERTIGO (Vertigo), VACCINATION COMPLICATION (Reacted pretty significantly), FEELING ABNORMAL (Felt a little funky), FATIGUE (Tired) and PYREXIA (Had a feeling like she was going to have a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-214611 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Jun-2021 and was forwarded to Moderna on 09-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of VERTIGO (Vertigo), VACCINATION COMPLICATION (Reacted pretty significantly), FEELING ABNORMAL (Felt a little funky), FATIGUE (Tired) and PYREXIA (Had a feeling like she was going to have a fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo), VACCINATION COMPLICATION (Reacted pretty significantly), FEELING ABNORMAL (Felt a little funky), FATIGUE (Tired) and PYREXIA (Had a feeling like she was going to have a fever). At the time of the report, VERTIGO (Vertigo), VACCINATION COMPLICATION (Reacted pretty significantly), FEELING ABNORMAL (Felt a little funky), FATIGUE (Tired) and PYREXIA (Had a feeling like she was going to have a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-214611 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: have a headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (have a headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (have a headache). At the time of the report, HEADACHE (have a headache) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Hyperhidrosis, Injection site pruritus, Injection site warmth
Clinical narrative: warm at injection site; "sweat through bedsheets went through 6 pillowcases"; 99.3 temperature; itchy at injection site; bump like a bug bite; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm at injection site), HYPERHIDROSIS ("sweat through bedsheets went through 6 pillowcases"), BODY TEMPERATURE INCREASED (99.3 temperature), INJECTION SITE PRURITUS (itchy at injection site) and VACCINATION SITE SWELLING (bump like a bug bite) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C24C and 009D21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (bicep surgery) and Vasectomy. Concomitant products included LISINOPRIL, DULOXETINE and PRAVASTATIN for an unknown indication.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced INJECTION SITE WARMTH (warm at injection site), HYPERHIDROSIS ("sweat through bedsheets went through 6 pillowcases"), BODY TEMPERATURE INCREASED (99.3 temperature) and INJECTION SITE PRURITUS (itchy at injection site). 07-Jun-2021, the patient experienced VACCINATION SITE SWELLING (bump like a bug bite). The patient was treated with TRAMADOL for Pain, at a dose of UNK dosage form. At the time of the report, INJECTION SITE WARMTH (warm at injection site), HYPERHIDROSIS ("sweat through bedsheets went through 6 pillowcases"), BODY TEMPERATURE INCREASED (99.3 temperature), INJECTION SITE PRURITUS (itchy at injection site) and VACCINATION SITE SWELLING (bump like a bug bite) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jun-2021, Body temperature: borderline (Borderline) 99.3.         Patient reports taking Multivitamins (NOS).    This case was linked to MOD-2021-214591 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: warm at injection site; "sweat through bedsheets went through 6 pillowcases"; 99.3 temperature; itchy at injection site; bump like a bug bite; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm at injection site), HYPERHIDROSIS ("sweat through bedsheets went through 6 pillowcases"), BODY TEMPERATURE INCREASED (99.3 temperature), INJECTION SITE PRURITUS (itchy at injection site) and VACCINATION SITE SWELLING (bump like a bug bite) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C24C and 009D21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (bicep surgery) and Vasectomy. Concomitant products included LISINOPRIL, DULOXETINE and PRAVASTATIN for an unknown indication.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced INJECTION SITE WARMTH (warm at injection site), HYPERHIDROSIS ("sweat through bedsheets went through 6 pillowcases"), BODY TEMPERATURE INCREASED (99.3 temperature) and INJECTION SITE PRURITUS (itchy at injection site). 07-Jun-2021, the patient experienced VACCINATION SITE SWELLING (bump like a bug bite). The patient was treated with TRAMADOL for Pain, at a dose of UNK dosage form. At the time of the report, INJECTION SITE WARMTH (warm at injection site), HYPERHIDROSIS ("sweat through bedsheets went through 6 pillowcases"), BODY TEMPERATURE INCREASED (99.3 temperature), INJECTION SITE PRURITUS (itchy at injection site) and VACCINATION SITE SWELLING (bump like a bug bite) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jun-2021, Body temperature: borderline (Borderline) 99.3.         Patient reports taking Multivitamins (NOS).    This case was linked to MOD-2021-214591 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot; itchy; swelling; Pain; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot ), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (red ) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047-C21A) for COVID-19 vaccination.     Concomitant products included ZINC and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced VACCINATION SITE WARMTH (hot ), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (red ). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (hot ), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (red ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included edibles.  No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: experiencing numbness in my hands; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (experiencing numbness in my hands) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (experiencing numbness in my hands). At the time of the report, HYPOAESTHESIA (experiencing numbness in my hands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: headache; body pains; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and MYALGIA (body pains) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, the patient experienced HEADACHE (headache) and MYALGIA (body pains). At the time of the report, HEADACHE (headache) and MYALGIA (body pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Nausea, Pruritus, Throat tightness
Clinical narrative: Itching (whole body); Throat tightening; Shaking; Blood Pressure increased; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching (whole body)), THROAT TIGHTNESS (Throat tightening), TREMOR (Shaking), BLOOD PRESSURE INCREASED (Blood Pressure increased) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PRURITUS (Itching (whole body)), THROAT TIGHTNESS (Throat tightening), TREMOR (Shaking), BLOOD PRESSURE INCREASED (Blood Pressure increased) and NAUSEA (Nausea). On 24-Apr-2021, PRURITUS (Itching (whole body)), THROAT TIGHTNESS (Throat tightening), TREMOR (Shaking), BLOOD PRESSURE INCREASED (Blood Pressure increased) and NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Blood pressure measurement: 191/92 mmHg (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Itching (whole body); Throat tightening; Shaking; Blood Pressure increased; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching (whole body)), THROAT TIGHTNESS (Throat tightening), TREMOR (Shaking), BLOOD PRESSURE INCREASED (Blood Pressure increased) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PRURITUS (Itching (whole body)), THROAT TIGHTNESS (Throat tightening), TREMOR (Shaking), BLOOD PRESSURE INCREASED (Blood Pressure increased) and NAUSEA (Nausea). On 24-Apr-2021, PRURITUS (Itching (whole body)), THROAT TIGHTNESS (Throat tightening), TREMOR (Shaking), BLOOD PRESSURE INCREASED (Blood Pressure increased) and NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Blood pressure measurement: 191/92 mmHg (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Hypersensitivity, Lip disorder, Swelling
Clinical narrative: swelling developed, looked like a chipmunk; swelling developed that got worse; tightness to lips; sensitivity; This spontaneous case was reported by a physician and describes the occurrence of SWELLING (swelling developed, looked like a chipmunk), CONDITION AGGRAVATED (swelling developed that got worse), LIP DISORDER (tightness to lips) and HYPERSENSITIVITY (sensitivity) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Skin cosmetic procedure (Filler injection with Restylane in "smoker's lines") on 01-Jun-2021.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling developed, looked like a chipmunk), CONDITION AGGRAVATED (swelling developed that got worse), LIP DISORDER (tightness to lips) and HYPERSENSITIVITY (sensitivity). At the time of the report, SWELLING (swelling developed, looked like a chipmunk), CONDITION AGGRAVATED (swelling developed that got worse), LIP DISORDER (tightness to lips) and HYPERSENSITIVITY (sensitivity) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was not reported.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia
Clinical narrative: redness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) and ERYTHEMA (redness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, the patient experienced MYALGIA (Sore arm). On an unknown date, the patient experienced ERYTHEMA (redness). At the time of the report, MYALGIA (Sore arm) and ERYTHEMA (redness) outcome was unknown.            Concomitant medications were not provided by the reporter. Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headaches). At the time of the report, HEADACHE (Headaches) outcome was unknown.           AE submitted. Patient had a query of how to get rid of headache after vaccination. Patient Used Tylenol but it's not helping.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first Moderna shot March 15th - but have not gotten the second shot  as of yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first Moderna shot March 15th - but have not gotten the second shot  as of yet) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first Moderna shot March 15th - but have not gotten the second shot  as of yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first Moderna shot March 15th - but have not gotten the second shot  as of yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Feeling cold, Lymph node pain
Clinical narrative: she began to feel chills, was very cold, couldn't get warm; Hard time breathing; Felt as if I actually had Covid; swollen lymph nodes (left side), under the arm pit, it was very painful; still feeling fatigue; Swollen lymph nodes (left side), under the arm pit, very painful, close to breast; Chills; Arm swollen at injection site area covered size of her hand; Body aches; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (she began to feel chills, was very cold, couldn't get warm), DYSPNOEA (Hard time breathing), MALAISE (Felt as if I actually had Covid), LYMPH NODE PAIN (swollen lymph nodes (left side), under the arm pit, it was very painful) and FATIGUE (still feeling fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Iron deficiency. Concomitant products included ATENOLOL, CHLORTALIDONE (ATENOLOL AND CHLORTHALIDONE) for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramedullar) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING COLD (she began to feel chills, was very cold, couldn't get warm), DYSPNOEA (Hard time breathing), MALAISE (Felt as if I actually had Covid), LYMPH NODE PAIN (swollen lymph nodes (left side), under the arm pit, it was very painful), FATIGUE (still feeling fatigue), LYMPHADENOPATHY (Swollen lymph nodes (left side), under the arm pit, very painful, close to breast), CHILLS (Chills), VACCINATION SITE SWELLING (Arm swollen at injection site area covered size of her hand), MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, FEELING COLD (she began to feel chills, was very cold, couldn't get warm), DYSPNOEA (Hard time breathing), MALAISE (Felt as if I actually had Covid), LYMPH NODE PAIN (swollen lymph nodes (left side), under the arm pit, it was very painful), FATIGUE (still feeling fatigue), LYMPHADENOPATHY (Swollen lymph nodes (left side), under the arm pit, very painful, close to breast), CHILLS (Chills), VACCINATION SITE SWELLING (Arm swollen at injection site area covered size of her hand), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramedullar), the reporter did not provide any causality assessments.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Myalgia, Pyrexia, Vaccination site swelling
Clinical narrative: she began to feel chills, was very cold, couldn't get warm; Hard time breathing; Felt as if I actually had Covid; swollen lymph nodes (left side), under the arm pit, it was very painful; still feeling fatigue; Swollen lymph nodes (left side), under the arm pit, very painful, close to breast; Chills; Arm swollen at injection site area covered size of her hand; Body aches; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (she began to feel chills, was very cold, couldn't get warm), DYSPNOEA (Hard time breathing), MALAISE (Felt as if I actually had Covid), LYMPH NODE PAIN (swollen lymph nodes (left side), under the arm pit, it was very painful) and FATIGUE (still feeling fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Iron deficiency. Concomitant products included ATENOLOL, CHLORTALIDONE (ATENOLOL AND CHLORTHALIDONE) for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramedullar) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING COLD (she began to feel chills, was very cold, couldn't get warm), DYSPNOEA (Hard time breathing), MALAISE (Felt as if I actually had Covid), LYMPH NODE PAIN (swollen lymph nodes (left side), under the arm pit, it was very painful), FATIGUE (still feeling fatigue), LYMPHADENOPATHY (Swollen lymph nodes (left side), under the arm pit, very painful, close to breast), CHILLS (Chills), VACCINATION SITE SWELLING (Arm swollen at injection site area covered size of her hand), MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, FEELING COLD (she began to feel chills, was very cold, couldn't get warm), DYSPNOEA (Hard time breathing), MALAISE (Felt as if I actually had Covid), LYMPH NODE PAIN (swollen lymph nodes (left side), under the arm pit, it was very painful), FATIGUE (still feeling fatigue), LYMPHADENOPATHY (Swollen lymph nodes (left side), under the arm pit, very painful, close to breast), CHILLS (Chills), VACCINATION SITE SWELLING (Arm swollen at injection site area covered size of her hand), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramedullar), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Nausea, Pyrexia
Clinical narrative: Cough; Chills; Headache; Nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 302B21A and 002A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced COUGH (Cough), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at a dose of UNK dosage form; LORATADINE at a dose of UNK dosage form; BENZONATATE at a dose of UNK dosage form and CYMBOPOGON SCHOENANTHUS (RICOLA [CYMBOPOGON SCHOENANTHUS]) at a dose of UNK dosage form. At the time of the report, COUGH (Cough), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was taking a water pill (not specified) concomitantly.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Report side effect.; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Report side effect.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report side effect.). At the time of the report, VACCINATION COMPLICATION (Report side effect.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Lasting side effect three months after second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Lasting side effect three months after second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Lasting side effect three months after second shot). At the time of the report, VACCINATION COMPLICATION (Lasting side effect three months after second shot) outcome was unknown.            No concomitant medications was provided. No treatment medication were provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever is 38 Celsius; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever is 38 Celsius) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever is 38 Celsius). At the time of the report, PYREXIA (fever is 38 Celsius) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Is it normal to for your arm to swell/Is it normal for your arm to swell after you get shot one; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Is it normal to for your arm to swell/Is it normal for your arm to swell after you get shot one) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Is it normal to for your arm to swell/Is it normal for your arm to swell after you get shot one). At the time of the report, PERIPHERAL SWELLING (Is it normal to for your arm to swell/Is it normal for your arm to swell after you get shot one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported. No Treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I got sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I got sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I got sick). At the time of the report, ILLNESS (I got sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Neck pain, Neuralgia
Clinical narrative: strong pain in neck; muscle pain, sore arm,; hurt shoulder; nerve pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (strong pain in neck), MYALGIA (muscle pain, sore arm,), ARTHRALGIA (hurt shoulder) and NEURALGIA (nerve pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PREDNISOLONE, APIXABAN (ELIQUIS), GABAPENTIN, LEVETIRACETAM, ALLOPURINOL, TOPIRAMATE, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), POTASSIUM, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and PARACETAMOL (TYLENOL) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced NECK PAIN (strong pain in neck), MYALGIA (muscle pain, sore arm,), ARTHRALGIA (hurt shoulder) and NEURALGIA (nerve pain). On 10-Mar-2021, NECK PAIN (strong pain in neck), MYALGIA (muscle pain, sore arm,), ARTHRALGIA (hurt shoulder) and NEURALGIA (nerve pain) outcome was unknown. Not Provided          The action taken with the drug was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: 4th day after the shot...I was at work got diarrhea that lasted for 5hrs; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (4th day after the shot...I was at work got diarrhea that lasted for 5hrs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (4th day after the shot...I was at work got diarrhea that lasted for 5hrs). At the time of the report, DIARRHOEA (4th day after the shot..I was at work got diarrhea that lasted for 5hrs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Fatigue, Headache, Inflammation, Muscle injury
Clinical narrative: muscles were damaged; blood test value in 430; oxygen went down to 73; inflammation on her back; fatigue/fatigues when she drives/fatigues when she goes down the stairs/blood test value in 430; headache; agitated; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of AGITATION (agitated), MUSCLE INJURY (muscles were damaged), BLOOD TEST ABNORMAL (blood test value in 430), OXYGEN SATURATION DECREASED (oxygen went down to 73) and INFLAMMATION (inflammation on her back) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PIROXICAM (PAXIL [PIROXICAM]) for Menopause, PANTOPRAZOLE and VITAMINS NOS for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced AGITATION (agitated) and HEADACHE (headache). On an unknown date, the patient experienced MUSCLE INJURY (muscles were damaged), BLOOD TEST ABNORMAL (blood test value in 430), OXYGEN SATURATION DECREASED (oxygen went down to 73), INFLAMMATION (inflammation on her back) and FATIGUE (fatigue/fatigues when she drives/fatigues when she goes down the stairs/blood test value in 430). The patient was treated with IBUPROFEN at an unspecified dose and frequency and NAPROXEN for Inflammation and Back pain, at a dose of 500 mg twice a day. At the time of the report, AGITATION (agitated), MUSCLE INJURY (muscles were damaged), BLOOD TEST ABNORMAL (blood test value in 430), OXYGEN SATURATION DECREASED (oxygen went down to 73), INFLAMMATION (inflammation on her back), FATIGUE (fatigue/fatigues when she drives/fatigues when she goes down the stairs/blood test value in 430) and HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: abnormal (abnormal) abnormal. On an unknown date, Oxygen saturation: 73 (Low) 73. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient visited her therapist and physical therapist   This case was linked to MOD-2021-214683 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow-up information received on 05-Jul-2021 contains updated reporter information added the treatment drug and updated the outcome of the events.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation, Oxygen saturation decreased
Clinical narrative: muscles were damaged; blood test value in 430; oxygen went down to 73; inflammation on her back; fatigue/fatigues when she drives/fatigues when she goes down the stairs/blood test value in 430; headache; agitated; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of AGITATION (agitated), MUSCLE INJURY (muscles were damaged), BLOOD TEST ABNORMAL (blood test value in 430), OXYGEN SATURATION DECREASED (oxygen went down to 73) and INFLAMMATION (inflammation on her back) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PIROXICAM (PAXIL [PIROXICAM]) for Menopause, PANTOPRAZOLE and VITAMINS NOS for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced AGITATION (agitated) and HEADACHE (headache). On an unknown date, the patient experienced MUSCLE INJURY (muscles were damaged), BLOOD TEST ABNORMAL (blood test value in 430), OXYGEN SATURATION DECREASED (oxygen went down to 73), INFLAMMATION (inflammation on her back) and FATIGUE (fatigue/fatigues when she drives/fatigues when she goes down the stairs/blood test value in 430). The patient was treated with IBUPROFEN at an unspecified dose and frequency and NAPROXEN for Inflammation and Back pain, at a dose of 500 mg twice a day. At the time of the report, AGITATION (agitated), MUSCLE INJURY (muscles were damaged), BLOOD TEST ABNORMAL (blood test value in 430), OXYGEN SATURATION DECREASED (oxygen went down to 73), INFLAMMATION (inflammation on her back), FATIGUE (fatigue/fatigues when she drives/fatigues when she goes down the stairs/blood test value in 430) and HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: abnormal (abnormal) abnormal. On an unknown date, Oxygen saturation: 73 (Low) 73. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient visited her therapist and physical therapist   This case was linked to MOD-2021-214683 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow-up information received on 05-Jul-2021 contains updated reporter information added the treatment drug and updated the outcome of the events.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity
Clinical narrative: My legs hurt; Headaches; arm still hurts/How long does this Muscle pain less ahead; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (arm still hurts/How long does this Muscle pain less ahead), PAIN IN EXTREMITY (My legs hurt) and HEADACHE (Headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced MYALGIA (arm still hurts/How long does this Muscle pain less ahead). On an unknown date, the patient experienced PAIN IN EXTREMITY (My legs hurt) and HEADACHE (Headaches). At the time of the report, PAIN IN EXTREMITY (My legs hurt) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Lyme disease, Myalgia, Pain in extremity
Clinical narrative: This spontaneous case reported by a patient, describes the occurrence of asthenia (felt crippled), pain in extremity (legs ached), arthralgia (joints ached so bad/pain in both shoulders) and myalgia (felt achy all over) in a male patient, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 044B21A) for COVID-19 immunization. No medical history reported. On Apr 21, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced asthenia (felt crippled), pain in extremity (legs ached), arthralgia (joints ached so bad/pain in both shoulders) and myalgia (felt achy all over). At the time of the report, asthenia (felt crippled), pain in extremity (legs ached), arthralgia (joints ached so bad/pain in both shoulders) and myalgia (felt achy all over) outcome: unknown. No concomitant and treatment information reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia
Clinical narrative: every night mild heart palpitation when she turn over and shift position/arrythmia very minor; This spontaneous case was reported by a consumer and describes the occurrence of ARRHYTHMIA (every night mild heart palpitation when she turn over and shift position/arrythmia very minor) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, PRAVASTATIN and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARRHYTHMIA (every night mild heart palpitation when she turn over and shift position/arrythmia very minor). At the time of the report, ARRHYTHMIA (every night mild heart palpitation when she turn over and shift position/arrythmia very minor) outcome was unknown.        The patient presented to a physician for symptoms of heart palpitations she initially experienced every night  when she would turn over and shift position. Eventually, the frequency greatly reduced and she was diagnosed with stress-induced arrhythmia.  No treatment was reported for the event.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: initial additional. On 09-Jul-2021: initial additional.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dizziness and diarrhea in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient had dizziness and diarrhea. At the time of the report, dizziness and diarrhea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.